Sucampo Pharmaceuticals Competitors and Similar CompaniesClear all
Sucampo Pharmaceuticals's competitors and similar companies include Amicus Therapeutics.
 Sucampo Pharmaceuticals Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis. |  Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | |
Founding Date | Founding Date 1996 | Founding Date 2002 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Rockville, US HQ Chiyoda, JP Chuo Ward, JP Kita Ward, JP Sanda Shi, JP Zug, CH Milton, GB | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more |
Employees | Employees 37 | Employees 58415% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $230.1m (FY, 2016) | Revenue (est.) $634.2m (FY, 2025) |
Cost of goods | Cost of goods $76m (FY, 2016) | Cost of goods $72.9m (FY, 2025) |
Gross profit | Gross profit $154.1m (FY, 2016) | Gross profit $561.3m (FY, 2025) |
Net income | Net income $18.5m (FY, 2016) | Net income ($27.1m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Amicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company